Skye Bioscience Inc.在交易完成后的新公司中，其自身持股比例仅为5.38%。相比之下，Redx的持股比例高达46.17%，而参与融资的投资者则总计持有48.45%的股份。这一股权分配格局，清晰揭示了各方在合并实体中的权重大小。
Skye Bioscience Inc.在交易完成后的新公司中，其自身持股比例仅为5.38%。相比之下，Redx的持股比例高达46.17%，而参与融资的投资者则总计持有48.45%的股份。这一股权分配格局，清晰揭示了各方在合并实体中的权重大小。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.